Los Angeles, CA -- (SBWire) -- 03/23/2019 --This report studies the Bipolar Disorder market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity levels.
People suffering from bipolar disorder have intense emotional states that occur in distinct periods called mood episodes. Mood episode is characterized by drastic changes in a person's usual mood and their behavior. Mood episode is mainly classified into two main types: manic episodes and depressive episodes. An overexcited or joyful state is called a manic episode and an extremely hopeless or sad state is called a depressive episode. Sometimes, a mood episode includes symptoms of both depression and mania, known as a mixed state. These mood episodes hamper school and job performance.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/792403/global-digital-radiology-industry-research-report-growth-trends-and-competitive-analysis
In 2017, the global Bipolar Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2018 and 2025.
This report focuses on the global top players, covered
Glaxo SmithKline (GSK)
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka
AstraZeneca
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Market segment by Application, the market can be split into
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
The study objectives of this report are:
To study and forecast the market size of Bipolar Disorder in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Get Full Report Now at USD 4,900 @ https://www.qyresearch.com/settlement/pre/810a1058fdcb78c49a2a05e508e85b89,0,1,Global%20Digital%20Radiology%20Industry%20Research%20Report,%20Growth%20Trends%20and%20Competitive%20Analysis%202018-2025
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
Bipolar Disorder Drugs Market Analysis, Trends & Forecast to 2025: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly, Astellas Pharma